Professor Andrew Wilks: Ledger

Stories naming Professor Andrew Wilks. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.

Investor	Rounds	Invested
No investors recorded yet. Know one?

Company	Kind	Announced	Price	Sources
Professor Andrew Wilks is not recorded as having acquired anything.

Funding announcement

Professor got nothing from the $2.8b sale of his molecule, and that's okay

Profile of scientist-entrepreneur Andrew Wilks covering the GSK sale of his cancer molecule, his SYNthesis BioVentures fund's family-office backers, and portfolio plays including Aculeus Therapeutics.

Professor Andrew Wilks

Funding history

Investors

What Professor Andrew Wilks bought

People

Coverage

Professor got nothing from the $2.8b sale of his molecule, and that's okay